COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)

社区不信任和机构可信度措施 (COMMIT)

• 批准号: 10447250
• 负责人: C. DANIEL MULLINS
• 金额: $ 60.49万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-01-01 至 2023-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10447250
• 关键词: Address; Affect; Asthma; Baltimore; Baptist Church; Behavior; Behavioral; COVID-19; COVID-19 disparity; COVID-19 impact; COVID-19 morbidity; COVID-19 mortality; COVID-19 pandemic; COVID-19 prevention; COVID-19 testing; Centers for Disease Control and Prevention (U.S.); Clinical Research; Collaborations; Communities; Contracts; Data Reporting; Diabetes Mellitus; Disasters; Discrimination; Economics; Emotional; Ethics; Fostering; Foundations; Funding; Future; Goals; Grant; Health; Health Care Research; Health Disparities Research; Healthcare Systems; Hypertension; Infrastructure; Institutes; Institution; Lead; Lebanon; Light; Maryland; Measures; Medical; Methods; Modeling; Morbidity - disease rate; National Center for Advancing Translational Sciences; National Institute on Minority Health and Health Disparities; Obesity; Outcome; Patients; Pharmacy Schools; Pharmacy facility; Plant Roots; Population; Population Group; Predisposition; Public Health; RADx Underserved Populations; Recommendation; Research; Research Personnel; Resource Sharing; Risk; Running; SARS-CoV-2 infection; Seminal; Testing; Time; Training Programs; Translational Research; Treatment Effectiveness; Trust; Underrepresented Populations; Underserved Population; United States; United States National Institutes of Health; Universities; Virginia; Vulnerable Populations; Work; Workforce Development; base; behavior change; community engaged research; community organizations; disparity reduction; effectiveness evaluation; ethnic minority population; fighting; financial relationship; health care delivery; health disparity; health equity; improved; infection rate; insight; inter-institutional; lens; medical vulnerability; member; mortality; pandemic disease; patient oriented; population health; preference; public health emergency; racial bias; racial minority; racism; shared decision making; social; social health determinants; social vulnerability; treatment program; trustworthiness; uptake

PROJECT SUMMARY/ABSTRACT In the United States underserved and socially vulnerable populations have endured higher rates and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden has shown the light on the root causes of COVID-19 disparities such as longstanding systemic racial bias in health care delivery, discrimination, and poor social determinants of health that lead to health disparities for medical conditions such as asthma, diabetes, hypertension, and obesity, all of which increase risk and susceptibility to COVID-19 and its sequalae. To address these root causes, academic and other research institutions and health care systems must shift their lens from one that focuses solely on changing behaviors among underserved and vulnerable populations. Behaviors among health care and research institutions must change to breakdown the structural barriers to trust, testing, treatment, and prevention of COVID-19. Prior to asking patients and community members to trust in research and researchers, the focus should be on radical institutional transformation to advance trustworthiness. Trying to address social, ethical, and behavioral issues (SEBI) influencing access acceptability and uptake of COVID-19 testing during a pandemic is extremely challenging, yet achievable when there are existing community-academic partnerships. The distinction between trust and trustworthiness suggests that trustworthiness is an antecedent to trust. Our proposed study will employ a continuous engagement approach to advance institutional trustworthiness and improve the strength of an existing community-engaged research (CEnR) partnership as well as develop recommendations for the formation of similar inter-institutional partnerships with community organizations in underserved populations. In collaboration with community and community-based pharmacy partners, our Aims are: Aim 1: Codesign a sustainable model for trustworthy CEnR partnerships to address SEBI of COVID-19 testing Aim 2: Assess best practices of trustworthy CEnR partnerships to address COVID-19 testing SEBI factors Aim 3: Codevelop an ethically-congruent memorandum of commitment (MOC) template for CEnR partnerships for COVID-19 testing to advance trust through trustworthiness, transparency, and respect

项目概要/摘要 在美国，服务不足和社会弱势群体的发病率更高 COVID-19 感染、发病率和死亡率的差异。这种不成比例的负担 揭示了 COVID-19 差异的根本原因，例如长期存在的系统性 医疗保健服务中的种族偏见、歧视和不良的健康社会决定因素 导致哮喘、糖尿病、高血压等疾病的健康差异 肥胖，所有这些都会增加感染 COVID-19 及其后遗症的风险和易感性。致地址 这些根本原因、学术和其他研究机构以及医疗保健系统必须转变 他们的视角只专注于改变服务不足和服务不足的人群的行为 弱势群体。医疗保健和研究机构的行为必须改变 打破信任、检测、治疗和预防 COVID-19 的结构性障碍。事先的 要求患者和社区成员信任研究和研究人员，重点是 应进行彻底的制度变革以提高可信度。 尝试解决影响访问可接受性的社会、道德和行为问题 (SEBI) 在大流行期间进行 COVID-19 检测极具挑战性，但也是可以实现的 当存在现有的社区学术伙伴关系时。信任与信任的区别 可信度表明可信度是信任的前提。我们提出的研究将 采用持续参与的方法来提高机构的可信度 提高现有社区参与研究 (CEnR) 伙伴关系的强度以及 为与以下机构建立类似的机构间伙伴关系提出建议 服务不足人群的社区组织。 与社区和社区药房合作伙伴合作，我们的目标是： 目标 1：为值得信赖的 CEnR 合作伙伴关系共同设计可持续模型，以解决 SEBI 问题 COVID-19 测试 目标 2：评估值得信赖的 CEnR 合作伙伴的最佳实践，以解决 COVID-19 测试问题 SEBI因素 目标 3：共同开发符合道德的承诺备忘录 (MOC) 模板 CEnR 合作进行 COVID-19 测试，通过可信度增进信任， 透明度和尊重